8:50am ET
Health and Healthcare
4 Large Cap Biotech Stocks to Buy Before Earnings
A new research report from Cowen focuses on the top biotech stocks to buy before second-quarter earnings are reported.
Companies
Alexion Pharmaceuticals, Inc.
$182.50
â–² $0.00 (+0.00%) today
Markets closed · 6:49am ET
ALXN Coverage
Page 16
7:55am ET
Health and Healthcare
Short Sellers Back Off Big Biotech
24/7 Wall St. has reviewed the short interest in top biotech companies, without focusing on speculative companies.
7:50am ET
Health and Healthcare
Short Sellers Get More Selective on Big Biotech
The short interest data are out for the June 15 settlement date, and overall, short interest in the selected biotech stocks was mixed.
9:35am ET
Investing
5 Unusual Movers in the S&P 500
In the S&P 500, some stocks had significant moves this past week, and some were on exponential volume spikes as well.
9:05am ET
Investing
5 Top Performers for the Past Week
24/7 Wall St. has put together a list of companies that have outperformed the market this past week.
7:55am ET
Health and Healthcare
Short Sellers Lose Some Conviction Against Big Biotech
The May 29 short interest data have been compared with the previous figures, and for most of the selected biotech stocks, short interest has decreased.
8:25am ET
Health and Healthcare
Short Sellers Get Even More Ambitious Against Biotech Leaders
The short interest data are out for the May 15 settlement date. Biotech companies are considered a riskier group of stocks.
8:05am ET
Health and Healthcare
Short Sellers Start to Get Nervous on Biotech
The short interest data are out for the April 30 settlement date, and for most of the selected biotech stocks, short interest is down.
8:30am ET
Health and Healthcare
Why These 4 Biotech Stocks Could Be the Next Buyout Targets
A new research note from SunTrust Robinson Humphrey mentions four stocks that they think could possibly get swept up in the biotech M&A excitement.
10:00am ET
Health and Healthcare
Huge Buyout Highlights 4 Deutsche Bank Biotech Focus Stocks
In a new report, Deutsche Bank acknowledges that while the industry has shown recent weakness, now may be just the right time to add biotech stocks.
9:30am ET
Health and Healthcare
Is Alexion Grossly Overpaying for Synageva?
Biotech giant Alexion Pharmaceuticals announced Wednesday morning that it will acquire Synageva BioPharma.
Chris Lange 8:30am ET
Health and Healthcare
Short Sellers Become More Wary of Big Biotech
The short interest data are out for the April 15 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
8:35am ET
Health and Healthcare
Short Sellers Increase Their Bets Against Biotech Stocks
The March 31 short interest data have been compared with the March 13 figures, and for most of the selected biotech stocks, short interest has increased.
9:15am ET
Health and Healthcare
Major Biotech Is So-So for Short Sellers
The March 13 short interest data in top biotechs have been compared with the end of February figures, and across the board all the selected stocks have seen their short interest increase.
2:10pm ET
Health and Healthcare
How the Weaker Euro Is Impacting Biotech Earnings
Wells Fargo released a report Wednesday that considers the future of major biotech companies in relation to the weak euro.